Supplier
LABORATORIO BIO SHAR S.R.L.
R/214348000017
DEIRUPEcrawl4aiMapsIMPO
$ 1.253.465
Total received
- Contracts
- 13
- Agencies that bought from them
- 4
- Average contract
- $ 96.420
- Years with activity
- 4
- First contract
- 07 jul. 2003
- Last contract
- 04 dic. 2007
LABORATORIO BIO SHAR S.R.L. received $ 1,3 M from the Uruguayan state across 13 awards between 2003 and 2007. It sold to 4 agencies. Its largest buyer is NO VIGENTE Instituto Nacional del Cáncer, with 2% of recorded spending.
State Suppliers Registry (RUPE)
ACTIVO- Legal name
- LABORATORIO BIO SHAR S R L
- Fiscal domicile
- MONTEVIDEO, Montevideo COSIO PEDRO (MALVIN NORTE) 2336 View on Google Maps
Source: ARCE — Registro Único de Proveedores del Estado (RUPE), open data. Cross-referenced to the supplier by RUT.
Revenue by year
Who buys from them
Agencies ranked by amount awarded to this supplier.
- NO VIGENTE Instituto Nacional del Cáncer$ 7,3 M
- NO VIGENTE Hospital Pasteur$ 112.570
- NO VIGENTE Centro Departamental de Artigas$ 111.603
- NO VIGENTE Hospital Maciel$ 38.320
Client concentration
2%
NO VIGENTE Instituto Nacional del Cáncer
How much of their revenue comes from their largest buyer.
Contracts
View all| Subject | Agency | Date | Amount |
|---|---|---|---|
| CITARABINA · CITARABINA (INYECTABLE)… | NO VIGENTE Instituto Nacional del Cáncer | 04 dic. 2007 | $ 247.500 |
| CITARABINA · CICLOFOSFAMIDA | NO VIGENTE Instituto Nacional del Cáncer | 05 nov. 2007 | $ 264.000 |
| CITARABINA · CICLOFOSFAMIDA | NO VIGENTE Instituto Nacional del Cáncer | 05 oct. 2007 | $ 109.200 |
| FLUDARABINA (COMPRIMIDOS) · ACIDO IBANDRONICO… | NO VIGENTE Instituto Nacional del Cáncer | 01 oct. 2007 | $ 284.246 |
| FLUDARABINA · ACIDO IBANDRONICO… | NO VIGENTE Instituto Nacional del Cáncer | 30 ago. 2007 | $ 421.158 |
| FLUDARABINA · ACIDO IBANDRONICO… | NO VIGENTE Instituto Nacional del Cáncer | 14 ago. 2007 | $ 394.812 |
| ESTROGENO-ANDROGENO · FLUDARABINA… | NO VIGENTE Instituto Nacional del Cáncer | 20 jul. 2007 | $ 3,2 M |
| ESTROGENO-ANDROGENO · ACIDO IBANDRONICO… | NO VIGENTE Instituto Nacional del Cáncer | 01 jun. 2007 | $ 2,3 M |
13 suppliers